MedTrace Logo

Pain Associated With Endometriosis

NCT00758953 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2012-03-06

No results posted yet for this study

Summary

This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.

Conditions

  • Endometriosis

Interventions

DRUG

Danazol Once Weekly

semi-solid

DRUG

Danazol Twice Weekly

semi-solid

DRUG

Placebo Once Weekly

semi-solid

DRUG

Placebo Twice Weekly

semi-solid

Sponsors & Collaborators

  • Lumara Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Jim Joffrion · Lumara Health, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • United States
  • Canada
  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00758953 on ClinicalTrials.gov